<?xml version="1.0" encoding="UTF-8"?>
<p>In addition to reporting rapid experimentally identified and validated combination therapies against VSV infection of A549, this work also discusses key further studies needed, and provides global health and healthcare economics policy perspectives that may provide a roadmap toward the broader clinical deployment of Project IDentif.AI. Collectively, these analyses demonstrate that technology and innovative policy considerations are needed to drive advances in clinical practice in addressing pre‚Äêpandemic and pandemic challenges.</p>
